January 2012
 

• FULL-TEXT PDF ARTICLE
  Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate
  and protease inhibitors.
  Pontrelli G, Cotugno N, Amodio D,  et al BMC Infect Dis. 2012 Jan 23;12(1):18.
• Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir:
  A Randomized, Placebo-Controlled Trial.
  Havens PL, Stephensen CB, Hazra R,  et alClin Infect Dis. 2012 Jan 19. 
• A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine
  in human plasma and its application to a pharmacokinetic study.
  Matta MK, Burugula L, Pilli NR, et al Biomed Chromatogr. 2012 Jan 4. 
• A WEEK-IN-REVIEW FEATURED REPORT
  FULL-TEXT ARTICLE
  Renal Function Declines More in Tenofovir- than Abacavir-Based Antiretroviral Therapy in Low-Body
  Weight Treatment-Naïve Patients with HIV Infection.
  Nishijima T, Gatanaga H, Komatsu H, et al PLoS One. 2012;7(1):e29977.
• Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir
  for the prevention of HIV infection.
  Ham AS, Ugaonkar SR, Shi L, et al J Pharm Sci. 2012 Jan 6.
• Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.
  Moss JA, Baum MM, Malone AM,  et al AIDS. 2012 Jan 4
• Sensitive and Rapid HPLC Quantification of Tenofovir from Hyaluronic Acid-Based Nanomedicine.
  Agrahari V, Youan BB. AAPS PharmSciTech. 2012 Jan 4
• Low concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir
  Best BM, Letendre SL, Koopmans P, et al J Acquir Immune Defic Syndr. 2012 Jan 3